Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis

Dykewicz, 1998, Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology, Ann Allergy Asthma Immunol, 81, 478, 10.1016/S1081-1206(10)63155-9 Thompson, 2000, Quality of life in patients with allergic rhinitis, Ann Allergy Asthma Immunol, 85, 338, 10.1016/S1081-1206(10)62543-4 Settipane, 2001, Demographics and epidemiology of allergic and nonallergic rhinitis, Allergy Asthma Proc, 22, 185 Settipane, 2001, Update on nonallergic rhinitis, Ann Allergy Asthma Immunol, 86, 494, 10.1016/S1081-1206(10)62896-7 Settipane, 2002, Nonallergic rhinitis, 53 Shin, 1992, The effect of azelastine on the early allergic response, Clin Exp Allergy, 22, 289, 10.1111/j.1365-2222.1992.tb03085.x Shinoda, 1997, Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions, Am J Rhinol, 11, 237, 10.2500/105065897781751901 Ito, 1998, Effects of azelastine on the level of serum interleukin-4 and soluble CD23 antigen in the treatment of nasal allergy, Arzneim-Forsch, 48, 1143 Ciprandi, 1996, Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity, J Allergy Clin Immunol, 98, 1088, 10.1016/S0091-6749(96)80196-5 Cheria-Sammari, 1995, Leukotriene B4 production by blood neutrophils in allergic rhinitis: effects of cetirizine, Clin Exp Allergy, 25, 729, 10.1111/j.1365-2222.1995.tb00010.x Charlesworth, 1989, Effect of cetirizine on mast cell-mediator releasae and cellular traffic during the cutaneous late-phase reaction, J Allergy Clin Immunol, 83, 905, 10.1016/0091-6749(89)90104-8 Ciprandi, 1995, Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early-and late-phase reactions after allergen-specific challenge, J Allergy Clin Immunol, 95, 612, 10.1016/S0091-6749(95)70324-1 Corren, 2005, Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis, Clin Ther, 27, 543, 10.1016/j.clinthera.2005.04.012 Meltzer, 1995, A pharmacologic continuum in the treatment of rhinorrhea: the clinician as ecoctmist, J Allergy Clin Immunol, 95, 1147, 10.1016/S0091-6749(95)70220-2 Corren, 2005, Efficacy of azelastine nasal spray, cetirizine tablets, fluticasone nasal spray, and placebo in patients with seasonal allergic rhinitis [abstract], Ann Allergy Asthma Immunol, 94, 197 Juniper, 1999, Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire, J Allergy Clin Immunol, 104, 364, 10.1016/S0091-6749(99)70380-5 Howarth, 1999, Double-blind, placebocontrolled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis, J Allergy Clin Immunol, 104, 927, 10.1016/S0091-6749(99)70070-9 Hampel, 2003, Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis, Ann Allergy Asthma Immunol, 91, 354, 10.1016/S1081-1206(10)61682-1 Storms, 1994, Effectiveness of azelastine nasal solution in seasonal allergic rhinitis, ENT J, 73, 382 Banov, 2001, Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis, Ann Allergy Asthma Immunol, 86, 28, 10.1016/S1081-1206(10)62352-6 Lieberman, 2005, Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis, Curr Med Res Opin, 21, 611, 10.1185/030079905X41408 Juniper, 1991, Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis, Clin Exp Allergy, 21, 77, 10.1111/j.1365-2222.1991.tb00807.x Juniper, 1998, Rhinitis management: the patient's perspective, Clin Exp Allergy, 28, 34, 10.1046/j.1365-2222.1998.0280s6034.x Bousquet, 1994, Assessment of quality of life in patients with perennial rhinitis with the French version of the SF-36 health status questionnaire, J Allergy Clin Immunol, 94, 182, 10.1053/ai.1994.v94.a54939 Schipper, 1990, Definitions and conceptual issues, 11 Juniper, 1997, Measuring health-related quality of life in rhinitis, J Allergy Clin Immunol, 99, S742, 10.1016/S0091-6749(97)90000-2 Davies, 1996, Antihistamines: topical vs oral administration, Clin Exp Allergy, 26, S11, 10.1111/j.1365-2222.1996.tb00653.x Berger, 2003, Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine, Ann Allergy Asthma Immunol, 91, 205, 10.1016/S1081-1206(10)62179-5 LaForce, 2004, Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine, Ann Allergy Asthma Immunol, 93, 154, 10.1016/S1081-1206(10)61468-8 Georgitis, 1994, Nasal hyperthermia and simple irrigation for perennial rhinitis changes in inflammatory mediators, Chest, 106, 1487, 10.1378/chest.106.5.1487 Tomooka, 2000, Clinical study and literature review of nasal irrigation, Laryngoscope, 11, 1189, 10.1097/00005537-200007000-00023 Weiler, 1994, A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model, J Allergy Clin Immunol, 94, 972, 10.1016/0091-6749(94)90115-5 Meltzer, 1994, Azelastine nasal spray in the management of seasonal allergic rhinitis, Ann Allergy, 72, 354 Ratner, 1994, A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis, J Allergy Clin Immunol, 94, 818, 10.1016/0091-6749(94)90148-1 LaForce, 1996, Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis, Ann Allergy Asthma Immunol, 76, 181, 10.1016/S1081-1206(10)63420-5